Breakthrough in Neuro-Oncology: Vitamin B12 Derivative Shows Promise Against Glioblastoma
Comments Off on Breakthrough in Neuro-Oncology: Vitamin B12 Derivative Shows Promise Against Glioblastoma
July 1, 2026
Glioblastoma multiforme (GBM) has long been considered the "final frontier" of oncology. As the most aggressive and malignant form of primary brain cancer, its clinical prognosis remains grim. Despite the aggressive standard-of-care…
A New Frontier in Oncology: Researchers Identify Novel Compounds to Neutralize Lethal Pancreatic Cancer
Comments Off on A New Frontier in Oncology: Researchers Identify Novel Compounds to Neutralize Lethal Pancreatic Cancer
June 30, 2026
Pancreatic ductal adenocarcinoma (PDAC) has long remained one of the most formidable adversaries in clinical oncology. Characterized by its late diagnosis, aggressive biological behavior, and a notorious resistance to conventional chemotherapy, it…
